Ironwood Financial’s AbbVie ABBV Stock Holding History

Ironwood Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$747K	Buy	3,014 +17	+0.6%	+$3.66K	0.12%	104
2026 Q1	$652K	Sell	2,997 -54	-2%	-$12K	0.11%	102
2025 Q4	$671K	Buy	3,051 +1	+0%	+$228	0.11%	105
2025 Q3	$706K	Buy	3,050 +143	+5%	+$29.1K	0.13%	102
2025 Q2	$609K	Hold	2,907	–	–	0.13%	100
2025 Q1	$609K	Buy	2,907 +15	+0.5%	+$2.92K	0.13%	100
2024 Q4	$514K	Hold	2,892	–	–	0.11%	105
2024 Q3	$571K	Buy	2,892 +171	+6%	+$31.9K	0.12%	99
2024 Q2	$467K	Buy	2,721 +6	+0.2%	+$994	0.1%	107
2024 Q1	$494K	Hold	2,715	–	–	0.11%	108
2023 Q4	$421K	Sell	2,715 -196	-7%	-$28.6K	0.1%	111
2023 Q3	$434K	Hold	2,911	–	–	0.12%	100
2023 Q2	$392K	Hold	2,911	–	–	0.1%	106
2023 Q1	$464K	Hold	2,911	–	–	0.13%	97
2022 Q4	$470K	Hold	2,911	–	–	0.15%	92
2022 Q3	$391K	Hold	2,911	–	–	0.13%	86
2022 Q2	$446K	Hold	2,911	–	–	0.14%	81
2022 Q1	$472K	Hold	2,911	–	–	0.13%	82
2021 Q4	$394K	Hold	2,911	–	–	0.11%	95
2021 Q3	$314K	Buy	2,911 +311	+12%	+$35.5K	0.09%	96
2021 Q2	$293K	Sell	2,600 -96	-4%	-$10.8K	0.09%	95
2021 Q1	$292K	Hold	2,696	–	–	0.1%	93
2020 Q4	$289K	Buy	2,696 +2,362	+707%	+$227K	0.11%	87
2020 Q3	$29K	Hold	334	–	–	0.01%	150
2020 Q2	$33K	Buy	334 +38	+13%	+$3.35K	0.02%	132
2020 Q1	$23K	Buy	296 +82	+38%	+$6.99K	0.02%	131
2019 Q4	$19K	Hold	214	–	–	0.01%	209
2019 Q3	$16K	Hold	214	–	–	0.01%	222
2019 Q2	$16K	Hold	214	–	–	0.01%	226
2019 Q1	$17K	Hold	214	–	–	0.01%	214
2018 Q4	$20K	Hold	214	–	–	0.01%	179
2018 Q3	$20K	Hold	214	–	–	0.01%	189
2018 Q2	$20K	Hold	214	–	–	0.01%	158
2018 Q1	$20K	Hold	214	–	–	0.02%	137
2017 Q4	$21K	Hold	214	–	–	0.01%	136
2017 Q3	$19K	Hold	214	–	–	0.01%	148
2017 Q2	$16K	Hold	214	–	–	0.01%	151
2017 Q1	$14K	Hold	214	–	–	0.01%	155
2016 Q4	$13K	Hold	214	–	–	0.01%	156
2016 Q3	$13K	Hold	214	–	–	0.01%	155
2016 Q2	$13K	Hold	214	–	–	0.01%	155
2016 Q1	$12K	Buy	+214	New	+$11.9K	0.01%	161
2015 Q3	$12K	Hold	214	–	–	0.01%	197
2015 Q2	$14K	Hold	214	–	–	0.01%	182
2015 Q1	$13K	Sell	214 -7	-3%	-$423	0.01%	191
2014 Q4	$14K	Buy	+221	New	+$13.9K	0.01%	158

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ironwood Financial's ABBV Position: Q2 2026 in Review

Ironwood Financial increased its AbbVie (ABBV) stake by 0.57% in Q2 2026, buying an estimated $3.66K and bringing the position to 3,014 shares worth $747K. The position accounts for 0.12% of the portfolio, ranked #104.

Ironwood Financial first reported a position in ABBV in Q4 2014 and has held it in 46 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ironwood Financial held 3,014 shares of AbbVie worth $747K as of Q2 2026.
Ironwood Financial bought 17 AbbVie shares in Q2 2026, an estimated $3.66K.
AbbVie made up 0.12% of Ironwood Financial's portfolio in Q2 2026, its #104 holding.
Ironwood Financial first reported a position in AbbVie in Q4 2014 and has held it in 46 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ironwood Financial's 13F filing for Q2 2026, filed 17 Jul 2026.